Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-19

Clinical Trial Update: Investigation of Neuroserpin as an Autism Candidate Gene

View source ↗

Summary

A clinical trial investigating neuroserpin as a candidate gene for autism has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Autism | Status: TERMINATED